Keywords
How to Cite
Abstract
Neurological complications are very relevant in the current pandemic scenario. The virus has the Spike protein, which binds to the Angiotensin-Converting Enzyme 2 receptor (ACE2), receptor present in the body, triggering the infection. This enzyme is present in abundance in the respiratory epithelium, which explains the predominance of respiratory symptoms; however it is still found in neurons and glial cells, making the Central Nervous System (CNS), a possible target of the pathogen. The objective is to highlight the main neurological complications resulting from infection by the coronavirus agent of acute respiratory syndrome (SARS-CoV-2). Thus, we conducted a literature search based on the descriptors “Covid 19”, “Neurological disease” and “Complications”, with publication period between 2020 and 2021 on the MEDLINE, PubMed, Latin American and Caribbean Literature in Science Sciences platforms (LILACS), UpToDate and World Health Organization. The most persistent neurological complications found were: aphasia, dysgeusia, cerebrovascular diseases and encephalopathies. The neurological manifestations arising from COVID-19 are a reality and very complex , so further studies are needed to further evaluation and analysis of the consequences caused by this virus infection.
References
BRANDÃO, A. S. et al. COVID-19 e complicações neurológicas: uma pequena revisão sistemática. Revista Neurociência, v. 29, p. 1-16, fev 2021. Disponível em: <https://periodicos.unifesp.br/index.php/neurociencias/article/view/11769/8425>.
ELKIND, M.S.V.; CUCCHIARA, B. L; KORALNIK, I.J. COVID-19: Neurologic complications and management of neurologic conditions. UpToDate, abr 2021.
FERINI-STRAMBI, L.; SALSONE, M. COVID-19 and neurological disorders: are neurodegenerative or neuroimmunological diseases more vulnerable? Journal of Neurology, V. 268, p. 409-419, jul 2020. Disponível em: <https://link.springer.com/article/10.1007/s00415-020-10070-8>.
MAO, L et al. Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China. JAMA Neurol., v. 77, n. 6, p. 683–690.
NAJJAR, S., et al. Central nervous system complications associated with SARS-CoV-2 infection: integrative concepts of pathophysiology and case reports. J Neuroinflammation, v. 17, n. 231, aug 2020. Disponível em: <https://doi.org/10.1186/s12974-020-01896-0>.
NEEDHAM, EJ et al. Implicações neurológicas das infecções por COVID-19. Neurocrit Care, v. 32, p. 667-671, abr 2020. Disponível em: <https://doi.org/10.1186/s12974-020-01896-0>.
SINGH, A. K., et al. Novel coronavirus disease 2019 (COVID‐19) and neurodegenerative disorders, Dermatol Ther, mai 2020. Disponível em: <https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7261984/>.
SOUZA, M. S., et al. Neurological complications of Covid-19: Narrative review. Jornal Memorial da Medicina, v. 2, n. 1, p. 29–37, dez 2020. Disponível em: <https://doi.org/10.37085/jmmv2.n1.2020.pp.29-37>.
TAHIRA, A.C; VERJOVSKI‐ALMEIDA, S; FERREIRA, ST. Dementia is an age‐independent risk factor for severity and death in COVID‐19 inpatients. Alzheimer ‘s Dement, p. 1-14, abr 2021. Disponível em: <https://alz-journals.onlinelibrary.wiley.com/doi/full/10.1002/alz.12352>.
VAIRA, L. A. et al. Anosmia and Ageusia: Common Findings in COVID-19 Patients. Laryngoscope, v.130, p. 1787–1787, 2020.
VALENTIR, P., et al. COVID-19-Related Intracerebral Hemorrhage Frontiers in Aging Neuroscience, v. 12, p. 352, out 2020.
ZHOU, Fei, et al. Clinical course and risk factors for mortality of adult in patients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet, v. 395, p. 1054–62, mar 2020. Disponível em: <https://doi.org/10.1016/S0140-6736(20)30566-3>.